Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:16 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Early Phase 1CompletedINTERVENTIONAL

Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin

ClinicalTrials.gov · NCT01701180 · Registry updated: 2014-12-03

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2012-08. Completion: 2013-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Oxytocin: Syntocinon-Spray, Novartis
Placebo (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Department of Psychiatry, University of Bonn
Bonn, North Rhine-Westphalia, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting

ClinicalTrials.gov · NCT01081249 · Registry updated: 2014-10-16

Condition / research focus: Behavior; Anxiety
Sponsor: MacDonald, Kai, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2008-12. Completion: 2012-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo then intranasal oxytocin (drug)
Intranasal oxytocin then placebo (drug)

Where the study takes place — 1 listed sites

Kai MacDonald, MD 3368 2nd Ave Ste B
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Control of Blood Loss During Caesarean Section

ClinicalTrials.gov · NCT01412073 · Registry updated: 2014-10-07

Condition / research focus: Complications; Cesarean Section
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2011-09. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
Misoprostol (drug) — also listed as: cytotec

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

ClinicalTrials.gov · NCT02052258 · Registry updated: 2014-09-15

Condition / research focus: Opiate Dependence
Sponsor: MacDonald, Kai, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2013-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

UCSD Medical Center
San Diego, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage

ClinicalTrials.gov · NCT01866241 · Registry updated: 2014-09-08

Condition / research focus: Post Partum Hemorrhage
Sponsor: Mbarara University of Science and Technology
Countries with listed sites: Uganda
Registry dates and results: Start: 2012-11. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Prostaglandin, Cytotec

Where the study takes place — 1 listed sites

Mbarara Regional Referral Hospital
Mbarara, Mbarara, Uganda
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women

ClinicalTrials.gov · NCT02229721 · Registry updated: 2014-09-01

Condition / research focus: Female Sexual Dysfunction
Sponsor: Medical University of Vienna
Countries with listed sites: Austria
Registry dates and results: Start: 2012-06. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon Nasalspray (drug) — also listed as: Oxytocin
Placebo Nasalspray (drug)

Where the study takes place — 1 listed sites

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Vienna, State of Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression

ClinicalTrials.gov · NCT02191423 · Registry updated: 2014-07-16

Condition / research focus: Postpartum Depression
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2015-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
placebo (drug)
Dyadic psychotherapy (behavioral)

Where the study takes place — 1 listed sites

The Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety

ClinicalTrials.gov · NCT01551303 · Registry updated: 2014-06-30

Condition / research focus: Social Intelligence
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2009-02. Completion: 2012-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Center for Anxiety and Traumatic Stress Disorders (CATSD)
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Pre-Induction Cervical Ripening

ClinicalTrials.gov · NCT01390233 · Registry updated: 2014-05-30

Condition / research focus: Failed Labour
Sponsor: University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2013-05 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Prepidil Gel (drug)
Urinary Balloon Catheter (device) — also listed as: Foley Catheter
Combined Urinary Catheter & Prepidil Gel (other) — also listed as: Foley catheter, Prepidil Gel

Where the study takes place — 1 listed sites

Palmetto Health Richland Hospital
Columbia, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Treatment of Alcohol Withdrawal

ClinicalTrials.gov · NCT01212185 · Registry updated: 2014-05-13

Condition / research focus: Alcohol Withdrawal
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2011-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin spray (drug) — also listed as: Syntocinon Spray
intranasal spray without oxytocin (other)

Where the study takes place — 2 listed sites

University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
Central Regional Hospital
Raleigh, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Hemodynamic Effects

ClinicalTrials.gov · NCT00977769 · Registry updated: 2014-05-06

Condition / research focus: Effects of; Anesthesia, in Pregnancy
Sponsor: Oslo University Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2009-11. Completion: 2011-10 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin 100 µg (drug) — also listed as: Pabal, injection
oxytocin 5 u (drug) — also listed as: Syntocinon, injection
placebo (NaCl) (drug) — also listed as: Saline, injection

Where the study takes place — 2 listed sites

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, Norway
Site recruitment: Not reported
Division of Anesthesia and Intensive Care Medicine
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?

ClinicalTrials.gov · NCT01312272 · Registry updated: 2014-05-02

Condition / research focus: Schizophrenia
Sponsor: VA Greater Los Angeles Healthcare System
Countries with listed sites: United States
Registry dates and results: Start: 2011-04. Completion: 2012-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Inactive placebo nasal spray (drug)

Where the study takes place — 1 listed sites

West Los Angeles VA Healthcare Center
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

ClinicalTrials.gov · NCT00263796 · Registry updated: 2014-04-30

Condition / research focus: Autism
Sponsor: Anagnostou, Evdokia, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2006-03. Completion: 2012-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

ClinicalTrials.gov · NCT01983514 · Registry updated: 2014-04-23

Condition / research focus: Healthy Male Adults
Sponsor: OptiNose AS
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

8IU intranasal oxytocin (drug)
24 IU intranasal oxytocin (drug)
1 IU intravenous oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research - TOP Study
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Preterm Infants' Weight Gain Following Massage Therapy

ClinicalTrials.gov · NCT00029198 · Registry updated: 2014-04-10

Condition / research focus: Premature Birth
Sponsor: University of Miami
Countries with listed sites: United States
Registry dates and results: Start: 2003-04. Completion: 2008-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

massage (procedure)
Sham massage (procedure)

Where the study takes place — 1 listed sites

University of Miami School of Medicine
Miami, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Social Cognition in Frontotemporal Dementia

ClinicalTrials.gov · NCT01002300 · Registry updated: 2014-03-18

Condition / research focus: Frontotemporal Dementia; Pick's Disease
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada
Registry dates and results: Start: 2009-09. Completion: 2010-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Cognitive Neurology and Alzheimer's Research Centre, St. Joseph's Hospital
London, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?

ClinicalTrials.gov · NCT00257803 · Registry updated: 2014-03-17

Condition / research focus: Postpartum Hemorrhage
Sponsor: University of British Columbia
Countries with listed sites: Canada
Registry dates and results: Start: 2005-11. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Saline solution (drug)

Where the study takes place — 1 listed sites

BC Women's Hospital, Department of Anesthesia
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia

ClinicalTrials.gov · NCT00777166 · Registry updated: 2014-03-14

Condition / research focus: Myocardial Ischemia; Hypotension; Bloodloss
Sponsor: Uppsala University
Countries with listed sites: Sweden
Registry dates and results: Start: 2005-12. Completion: 2008-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon, Pitcotin
oxytocin (drug) — also listed as: Syntocinon, Pitcotin

Where the study takes place — 1 listed sites

University hospital Uppsala
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery

ClinicalTrials.gov · NCT02080104 · Registry updated: 2014-03-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Hediye Dagdeviren
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-02. Completion: 2015-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intarvenous and intramusculer 10 IU oxytocin (drug)

Where the study takes place — 1 listed sites

Bakırkoy Dr Sadi Konuk Teaching and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section

ClinicalTrials.gov · NCT02079558 · Registry updated: 2014-03-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Shahid Beheshti University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2012-09. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin,, Pabal,, Lonactene
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Infertility and Reproductive Health Research Center
Tehran, Tehran Province, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 01:16 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Early Phase 1CompletedINTERVENTIONAL

Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin

ClinicalTrials.gov · NCT01701180 · Registry updated: 2014-12-03

Condition / research focus: Healthy
Sponsor: University Hospital, Bonn
Countries with listed sites: Germany
Registry dates and results: Start: 2012-08. Completion: 2013-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Oxytocin: Syntocinon-Spray, Novartis
Placebo (drug)

Where the study takes place — 1 listed sites

Department of Psychiatry, University of Bonn
Bonn, North Rhine-Westphalia, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting

ClinicalTrials.gov · NCT01081249 · Registry updated: 2014-10-16

Condition / research focus: Behavior; Anxiety
Sponsor: MacDonald, Kai, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2008-12. Completion: 2012-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo then intranasal oxytocin (drug)
Intranasal oxytocin then placebo (drug)

Where the study takes place — 1 listed sites

Kai MacDonald, MD 3368 2nd Ave Ste B
San Diego, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Control of Blood Loss During Caesarean Section

ClinicalTrials.gov · NCT01412073 · Registry updated: 2014-10-07

Condition / research focus: Complications; Cesarean Section
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2011-09. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon
Misoprostol (drug) — also listed as: cytotec

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

ClinicalTrials.gov · NCT02052258 · Registry updated: 2014-09-15

Condition / research focus: Opiate Dependence
Sponsor: MacDonald, Kai, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2013-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

UCSD Medical Center
San Diego, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage

ClinicalTrials.gov · NCT01866241 · Registry updated: 2014-09-08

Condition / research focus: Post Partum Hemorrhage
Sponsor: Mbarara University of Science and Technology
Countries with listed sites: Uganda
Registry dates and results: Start: 2012-11. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Prostaglandin, Cytotec

Where the study takes place — 1 listed sites

Mbarara Regional Referral Hospital
Mbarara, Mbarara, Uganda
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women

ClinicalTrials.gov · NCT02229721 · Registry updated: 2014-09-01

Condition / research focus: Female Sexual Dysfunction
Sponsor: Medical University of Vienna
Countries with listed sites: Austria
Registry dates and results: Start: 2012-06. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Syntocinon Nasalspray (drug) — also listed as: Oxytocin
Placebo Nasalspray (drug)

Where the study takes place — 1 listed sites

Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Vienna, State of Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression

ClinicalTrials.gov · NCT02191423 · Registry updated: 2014-07-16

Condition / research focus: Postpartum Depression
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2015-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
placebo (drug)
Dyadic psychotherapy (behavioral)

Where the study takes place — 1 listed sites

The Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety

ClinicalTrials.gov · NCT01551303 · Registry updated: 2014-06-30

Condition / research focus: Social Intelligence
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2009-02. Completion: 2012-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

Center for Anxiety and Traumatic Stress Disorders (CATSD)
Boston, Massachusetts, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Pre-Induction Cervical Ripening

ClinicalTrials.gov · NCT01390233 · Registry updated: 2014-05-30

Condition / research focus: Failed Labour
Sponsor: University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2013-05 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Prepidil Gel (drug)
Urinary Balloon Catheter (device) — also listed as: Foley Catheter
Combined Urinary Catheter & Prepidil Gel (other) — also listed as: Foley catheter, Prepidil Gel

Where the study takes place — 1 listed sites

Palmetto Health Richland Hospital
Columbia, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Treatment of Alcohol Withdrawal

ClinicalTrials.gov · NCT01212185 · Registry updated: 2014-05-13

Condition / research focus: Alcohol Withdrawal
Sponsor: University of North Carolina, Chapel Hill
Countries with listed sites: United States
Registry dates and results: Start: 2010-07. Completion: 2011-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin spray (drug) — also listed as: Syntocinon Spray
intranasal spray without oxytocin (other)

Where the study takes place — 2 listed sites

University of North Carolina Hospitals
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
Central Regional Hospital
Raleigh, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Hemodynamic Effects

ClinicalTrials.gov · NCT00977769 · Registry updated: 2014-05-06

Condition / research focus: Effects of; Anesthesia, in Pregnancy
Sponsor: Oslo University Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2009-11. Completion: 2011-10 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin 100 µg (drug) — also listed as: Pabal, injection
oxytocin 5 u (drug) — also listed as: Syntocinon, injection
placebo (NaCl) (drug) — also listed as: Saline, injection

Where the study takes place — 2 listed sites

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, Norway
Site recruitment: Not reported
Division of Anesthesia and Intensive Care Medicine
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?

ClinicalTrials.gov · NCT01312272 · Registry updated: 2014-05-02

Condition / research focus: Schizophrenia
Sponsor: VA Greater Los Angeles Healthcare System
Countries with listed sites: United States
Registry dates and results: Start: 2011-04. Completion: 2012-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Inactive placebo nasal spray (drug)

Where the study takes place — 1 listed sites

West Los Angeles VA Healthcare Center
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

ClinicalTrials.gov · NCT00263796 · Registry updated: 2014-04-30

Condition / research focus: Autism
Sponsor: Anagnostou, Evdokia, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2006-03. Completion: 2012-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebo (drug)

Where the study takes place — 1 listed sites

Mount Sinai School of Medicine
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

ClinicalTrials.gov · NCT01983514 · Registry updated: 2014-04-23

Condition / research focus: Healthy Male Adults
Sponsor: OptiNose AS
Countries with listed sites: Norway
Registry dates and results: Start: 2013-10. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

8IU intranasal oxytocin (drug)
24 IU intranasal oxytocin (drug)
1 IU intravenous oxytocin (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research - TOP Study
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Preterm Infants' Weight Gain Following Massage Therapy

ClinicalTrials.gov · NCT00029198 · Registry updated: 2014-04-10

Condition / research focus: Premature Birth
Sponsor: University of Miami
Countries with listed sites: United States
Registry dates and results: Start: 2003-04. Completion: 2008-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

massage (procedure)
Sham massage (procedure)

Where the study takes place — 1 listed sites

University of Miami School of Medicine
Miami, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Oxytocin and Social Cognition in Frontotemporal Dementia

ClinicalTrials.gov · NCT01002300 · Registry updated: 2014-03-18

Condition / research focus: Frontotemporal Dementia; Pick's Disease
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada
Registry dates and results: Start: 2009-09. Completion: 2010-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Cognitive Neurology and Alzheimer's Research Centre, St. Joseph's Hospital
London, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?

ClinicalTrials.gov · NCT00257803 · Registry updated: 2014-03-17

Condition / research focus: Postpartum Hemorrhage
Sponsor: University of British Columbia
Countries with listed sites: Canada
Registry dates and results: Start: 2005-11. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Saline solution (drug)

Where the study takes place — 1 listed sites

BC Women's Hospital, Department of Anesthesia
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia

ClinicalTrials.gov · NCT00777166 · Registry updated: 2014-03-14

Condition / research focus: Myocardial Ischemia; Hypotension; Bloodloss
Sponsor: Uppsala University
Countries with listed sites: Sweden
Registry dates and results: Start: 2005-12. Completion: 2008-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: syntocinon, Pitcotin
oxytocin (drug) — also listed as: Syntocinon, Pitcotin

Where the study takes place — 1 listed sites

University hospital Uppsala
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery

ClinicalTrials.gov · NCT02080104 · Registry updated: 2014-03-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Hediye Dagdeviren
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-02. Completion: 2015-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intarvenous and intramusculer 10 IU oxytocin (drug)

Where the study takes place — 1 listed sites

Bakırkoy Dr Sadi Konuk Teaching and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section

ClinicalTrials.gov · NCT02079558 · Registry updated: 2014-03-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Shahid Beheshti University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2012-09. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin,, Pabal,, Lonactene
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Infertility and Reproductive Health Research Center
Tehran, Tehran Province, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →